These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16908826)

  • 1. Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
    Shields CL; Sun H; Manquez ME; Leahey A; Meadows AT; Shields JA
    Arch Ophthalmol; 2006 Aug; 124(8):1196-7. PubMed ID: 16908826
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of iris neovascularization following chemoreduction of retinoblastoma.
    Patel J; Turaka K; Shields CL
    J Pediatr Ophthalmol Strabismus; 2010 Oct; 47 Online():e1-3. PubMed ID: 21162463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the best treatment for retinoblastoma?
    Harbour JW
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract]   [Full Text] [Related]  

  • 4. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment.
    Shields CL; Materin MA; Shields JA
    Arch Ophthalmol; 2005 Nov; 123(11):1610-2. PubMed ID: 16286630
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical approach to management of retinoblastoma.
    Shields CL; Mashayekhi A; Demirci H; Meadows AT; Shields JA
    Arch Ophthalmol; 2004 May; 122(5):729-35. PubMed ID: 15136321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
    Rojanaporn D; Kaliki S; Bianciotto CG; Iturralde JC; Say EA; Shields CL
    Arch Ophthalmol; 2012 May; 130(5):585-90. PubMed ID: 22652844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinocytoma shows lack of response to chemoreduction.
    Chung J; Turaka K; Shields CL
    J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-3. PubMed ID: 21175116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H; Khetan V; Halliday W; Héon E; Chan HS; Gallie BL
    Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
    Sussman DA; Escalona-Benz E; Benz MS; Hayden BC; Feuer W; Cicciarelli N; Toledano S; Markoe A; Murray TG
    Arch Ophthalmol; 2003 Jul; 121(7):979-84. PubMed ID: 12860801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
    ElZomor H; Taha H; Aleieldin A; Nour R; Zaghloul MS; Fawzi M; Kamel A; Alfaar AS
    Ophthalmic Genet; 2015; 36(3):287-9. PubMed ID: 25945688
    [No Abstract]   [Full Text] [Related]  

  • 17. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL; Mashayekhi A; Au AK; Czyz C; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alive with good vision: the ultimate goal in managing retinoblastoma.
    Kivelä T
    Clin Exp Ophthalmol; 2012; 40(7):655-6. PubMed ID: 23046171
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
    Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
    J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.